Terms: = Pancreatic cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315
31721 results:
1. Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro.
Gbelcová H; Rimpelová S; Jariabková A; Macášek P; Priščáková P; Ruml T; Šáchová J; Kubovčiak J; Kolář M; Vítek L
Sci Rep; 2024 May; 14(1):11830. PubMed ID: 38782983
[TBL] [Abstract] [Full Text] [Related]
2. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
[TBL] [Abstract] [Full Text] [Related]
3. Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
Arias-Lorza AM; Costello JR; Hingorani SR; Von Hoff DD; Korn RL; Raghunand N
Sci Rep; 2024 May; 14(1):11570. PubMed ID: 38773189
[TBL] [Abstract] [Full Text] [Related]
4. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
[TBL] [Abstract] [Full Text] [Related]
5. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
6. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
[TBL] [Abstract] [Full Text] [Related]
7. Non-specific uptake of
Li Y; Gao J; Li Y; Duan X; Shen C
Sci Rep; 2024 May; 14(1):11141. PubMed ID: 38750103
[TBL] [Abstract] [Full Text] [Related]
8. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
9. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
[TBL] [Abstract] [Full Text] [Related]
10. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
[TBL] [Abstract] [Full Text] [Related]
11. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
12. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
[TBL] [Abstract] [Full Text] [Related]
13. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
[TBL] [Abstract] [Full Text] [Related]
14. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction.
Zeng J; Li X; Zhang Y; Zhang B; Wang H; Bao S; Zu L; Zhang H; Cheng Y; Tang Q; Xu X; Xu S; Song Z
Aging (Albany NY); 2024 May; 16(9):7647-7667. PubMed ID: 38728250
[TBL] [Abstract] [Full Text] [Related]
15. A clinical-radiomics nomogram based on dual-layer spectral detector CT to predict cancer stage in pancreatic ductal adenocarcinoma.
Wu L; Cen C; Yue X; Chen L; Wu H; Yang M; Lu Y; Ma L; Li X; Wu H; Zheng C; Han P
Cancer Imaging; 2024 May; 24(1):55. PubMed ID: 38725034
[TBL] [Abstract] [Full Text] [Related]
16. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
18. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study.
Poiraud C; Lenne X; Bruandet A; Theis D; Bertrand N; Turpin A; Truant S; El Amrani M
World J Surg Oncol; 2024 May; 22(1):123. PubMed ID: 38711136
[TBL] [Abstract] [Full Text] [Related]
20. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Lin KY; Chen PS; Lin CF
BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
[TBL] [Abstract] [Full Text] [Related]
[Next]
